South Korean researchers have developed a new technology that can recognize and detect lung diseases such as Chronic Obstructive Pulmonary Disease (COPD), lung fibrosis, asthma, etc., by utilizing ...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), a leading developer of eyonis™, a suite of ...

Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for ...

Electronic nose (e-nose) technology identified early-stage lung cancer with high reliability in a prospective observational clinical trial conducted at Memorial Sloan Kettering Cancer Center (MSK).

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. A new study led by researchers at Wake Forest University ...

Two new modeling studies suggest that expanding lung cancer screening — to include more smokers or even lifelong nonsmokers — would save thousands more lives in the US every year. But not everyone is ...

E-cigarette use among individuals eligible for lung cancer screening was independently associated with a reduced likelihood of screening, a cross-sectional study of U.S. adults revealed. Compared with ...

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

Lung cancer screening with low-dose CT could have saved tens of thousands of lives — if only we'd listened to the data back in the 1970s. Instead, fear of radiation, obsession with overdiagnosis, and ...

The Female Asian Nonsmoker Screening Study (FANSS) showed a 1.3% lung cancer detection rate among 1000 Asian women with no smoking history. The findings of FANSS, the largest lung cancer screening ...

Nina Thomas does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...